Clinical Trials on Depressive Disorder, Major

Total 144856 results

Eli Lilly and Company

Completed

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Major Depressive Disorder

United States, South Africa, Poland, Ukraine, Japan, Russian Federation, Latvia
Stanford University
National Institute of Mental Health (NIMH); The Dana Foundation

Completed

Brain Imaging of rTMS Treatment for Depression

Depression | Major Depressive Disorder

United States
Massachusetts General Hospital

Withdrawn

Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder

Major Depressive Disorder

United States
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Completed

Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression

Major Depressive Disorder

United States
Emory University

Terminated

Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression

Major Depressive Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH); University of Ottawa

Completed

Does Dual Therapy Hasten Antidepressant Response?

Major Depressive Disorder

United States, Canada
National Institute of Mental Health (NIMH)

Completed

FMRI Study of Performance During a Probabilistic Reversal Learning Task in Depression

Major Depressive Disorder

United States
University of Ontario Institute of Technology

Unknown

Impact of an Eight Week Exercise Intervention in Treating Major Depressive Disorder

Major Depressive Disorder

Canada
Massachusetts General Hospital

Terminated

N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression

Major Depressive Disorder

United States
Massachusetts General Hospital

Terminated

Neurobiological Bases of Placebo Response in Major Depressive Disorder

Major Depressive Disorder

United States
University of Utah
AlzChem, LLC

Completed

Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram

Major Depressive Disorder

United States
Merck Sharp & Dohme LLC

Completed

Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)

Major Depressive Disorder
Merck Sharp & Dohme LLC

Completed

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)

Major Depressive Disorder
Avera McKennan Hospital & University Health Center

Completed

Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis (PGX-AMG)

Major Depressive Disorder

United States
Merck Sharp & Dohme LLC

Completed

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)

Major Depressive Disorder
Taichung Veterans General Hospital

Completed

Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial

Major Depressive Disorder
Maurizio Fava, MD
Novartis Pharmaceuticals

Completed

Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability

Major Depressive Disorder

United States
Pfizer

Completed

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Major Depressive Disorder

United States, Chile, Mexico
University Hospital, Grenoble

Completed

Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks (KETADEP)

Major Depressive Disorder

France
e-Therapeutics PLC

Completed

Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD) (ETS6103-003)

Major Depressive Disorder

United Kingdom
Massachusetts General Hospital
Mclean Hospital

Completed

Brain GABA Levels and Treatment Response in Major Depressive Disorder

Major Depressive Disorder

United States
Hoffmann-La Roche

Completed

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Major Depressive Disorder

Germany, United States, Taiwan, Mexico, Poland, Russian Federation, Chile, Japan, Romania
University Medical Center Groningen

Unknown

Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder

Major Depressive Disorder
Mental Health Services in the Capital Region, Denmark
Mental Health Centre North Zealand

Unknown

Family Psychoeducation for Major Depressive Disorder

Major Depressive Disorder

Denmark
Sunovion

Completed

Major Depressive Disorder With Mixed Features - Extension (RESOLVE3)

Major Depressive Disorder

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Major Depressive Disorder

United States
Wave Neuroscience

Completed

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder (NEST-MDD)

Major Depressive Disorder

United States
Queen's University

Completed

Neurocognitive Enhancement in Major Depressive Disorder (MDDNET)

Major Depressive Disorder

Canada
D'Or Institute for Research and Education

Completed

Blame Rebalance fMRI Feedback Proof-of-concept (GUIMRINFB1)

Major Depressive Disorder

Brazil
H. Lundbeck A/S

Completed

A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder (PERFORM)

Major Depressive Disorder

France
University of Michigan
National Institute of Mental Health (NIMH)

Completed

Neuronal Responses to Social Feedback in Major Depressive Disorder

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Major Depressive Disorder

Japan
iHope Network, Inc.
UConn Health; Woburn Pediatric Associates

Completed

Study of Technology-assisted Treatment of Adolescent Depression (iTAD)

Major Depressive Disorder

United States
Massachusetts General Hospital

Completed

Internet-Based Depression Screening for College Students

Major Depressive Disorder

United States
University of British Columbia
Pfizer

Completed

Neurocognition and Work Productivity in Major Depressive Disorder (MDD)

Major Depressive Disorder

Canada
Sunnybrook Health Sciences Centre

Terminated

Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder

Major Depressive Disorder

Canada
James Murrough

Completed

Continuation Ketamine in Major Depression

Major Depressive Disorder

United States
Cervel Neurotech, Inc.

Completed

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Major Depressive Disorder

United States, Australia
H. Lundbeck A/S

Completed

A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication (REVIVE)

Major Depressive Disorder
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Massachusetts General Hospital
BrainCells Inc.

Completed

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Takeda

Completed

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Major Depressive Disorder

Japan
University of Texas at Austin

Completed

Testing the Effectiveness of a Computer-based Program for Depression

Major Depressive Disorder

United States
University of Texas Southwestern Medical Center
Eli Lilly and Company

Completed

Assessment of Cognitive Functioning Before and After Treatment With Duloxetine (DULOX)

Major Depressive Disorder

United States
Massachusetts General Hospital
Hope for Depression Research Foundation

Completed

Neural Correlates of Psychodynamic Psychotherapy for Depression

Major Depressive Disorder

United States
Herzog Hospital
Beersheva Mental Health Center

Terminated

Creatine as a New Therapeutic Strategy in Depression

Major Depressive Disorder

Israel
Douglas Mental Health University Institute
Brainsway

Completed

Effectiveness of Deep Transcranial Magnetic Stimulation in Depression

Major Depressive Disorder

Canada
H. Lundbeck A/S

Completed

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

Major Depressive Disorder

Austria, Russian Federation

Clinical Trials on Depressive Disorder, Major

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations